Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Leiden University Medical Center
Leiden, The Netherlands
Memorial Sloan Kettering Cancer Center
New York, United States
Erasmus MC
Rotterdam, The Netherlands
Washington University in St. Louis
St Louis, United States
Mayo Clinic
Rochester, United States
University Medical Center Utrecht
Utrecht, The Netherlands
Agostino Gemelli University Polyclinic
Rome, Italy
NYU Langone Health
New York, United States
Medisch Spectrum Twente
Enschede, The Netherlands
The University of Texas MD Anderson Cancer Center
Houston, United States
References
References (98)
- 1
Patterns and utility of routine surveillance in high grade endometrial cancer.
Hunn J, Tenney ME, Tergas AI, et al.
Gynecologic oncology 2015; (137(3)):485-9.
PMID: 25838164 - 2
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
Bosse T, Peters EE, Creutzberg CL, et al.
European journal of cancer (Oxford, England : 1990) 2015; (51(13)):1742-50.
PMID: 26049688 - 3
Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.
Meyer LA, Bohlke K, Powell MA, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015; (33(26)):2908-13 doi:10.1200/JCO.2015.62.5459.
PMID: 26150442 - 4
The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.
Cote ML, Ruterbusch JJ, Olson SH, et al.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015; (24(9)):1407-15 doi:10.1158/1055-9965.EPI-15-0316.
PMID: 26290568 - 5
Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial.
de Boer SM, Nout RA, Jürgenliemk-Schulz IM, et al.
International journal of radiation oncology, biology, physics 2015; (93(4)):797-809.
PMID: 26530748 - 6
The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis.
van Hanegem N, Prins MM, Bongers MY, et al.
European journal of obstetrics, gynecology, and reproductive biology 2016; (197()):147-55.
PMID: 26748390 - 7
Genetic counseling and cascade genetic testing in Lynch syndrome.
Hampel H
Familial cancer 2016; (15(3)):423-7 doi:10.1007/s10689-016-9893-5.
PMID: 26969309 - 8
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Stelloo E, Nout RA, Osse EM, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research 2016; (22(16)):4215-24 doi:10.1158/1078-0432.CCR-15-2878.
PMID: 27006490 - 9
Management of Iron Deficiency Anemia.
Jimenez K, Kulnigg-Dabsch S, Gasche C
Gastroenterology & hepatology 2015; (11(4)):241-50.
PMID: 27099596 - 10
Management of Deep Vein Thrombosis (DVT) Prophylaxis in Trauma Patients.
Paydar S, Sabetian G, Khalili H, et al.
Bulletin of emergency and trauma 2016; (4(1)):1-7.
PMID: 27162921 - 11
Diagnostic workup for postmenopausal bleeding: a randomised controlled trial.
van Hanegem N, Breijer MC, Slockers SA, et al.
BJOG : an international journal of obstetrics and gynaecology 2017; (124(2)):231-240 doi:10.1111/1471-0528.14126.
PMID: 27225535 - 12
Prognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancer.
Foerster R, Schnetzke L, Bruckner T, et al.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2016; (192(12)):895-904 doi:10.1007/s00066-016-1037-1.
PMID: 27605238 - 13
Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
Bendifallah S, Ouldamer L, Lavoue V, et al.
Gynecologic oncology 2017; (144(1)):107-112 doi:10.1016/j.ygyno.2016.10.025.
PMID: 27789083 - 14
Fertility-preservation in endometrial cancer: is it safe? Review of the literature.
Carneiro MM, Lamaita RM, Ferreira MC, Silva-Filho AL
JBRA assisted reproduction 2016; (20(4)):232-239 doi:10.5935/1518-0557.20160045.
PMID: 28050959 - 15
Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up.
Jeppesen MM, Mogensen O, Hansen DG, et al.
Acta oncologica (Stockholm, Sweden) 2017; (56(2)):262-269 doi:10.1080/0284186X.2016.1267396.
PMID: 28080157 - 16
Sexual Function and Quality of Life Among Patients With Endometrial Cancer After Surgery.
Gao H, Xiao M, Bai H, Zhang Z
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2017; (27(3)):608-612 doi:10.1097/IGC.0000000000000905.
PMID: 28129240 - 17
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Rossi EC, Kowalski LD, Scalici J, et al.
The Lancet. Oncology 2017; (18(3)):384-392 doi:10.1016/S1470-2045(17)30068-2.
PMID: 28159465 - 18
Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL, Gonzalez JL, DeMars L, et al.
Human pathology 2017; (70()):121-128 doi:10.1016/j.humpath.2017.10.022.
PMID: 29107668 - 19
Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.
Geppert B, Lönnerfors C, Bollino M, Persson J
Gynecologic oncology 2018; (148(3)):491-498 doi:10.1016/j.ygyno.2017.12.017.
PMID: 29273307 - 20
Factors Associated with Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis.
Sasaki LMP, Andrade KRC, Figueiredo ACMG, et al.
Journal of minimally invasive gynecology 2018; (25(5)):777-785 doi:10.1016/j.jmig.2018.02.004.
PMID: 29454147 - 21
ACOG Committee Opinion No. 734 Summary: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.
Obstetrics and gynecology 2018; (131(5)):945-946 doi:10.1097/AOG.0000000000002626.
PMID: 29683904 - 22
ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.
Obstetrics and gynecology 2018; (131(5)):e124-e129 doi:10.1097/AOG.0000000000002631.
PMID: 29683909 - 23
Role of bleeding recognition and evaluation in Black-White disparities in endometrial cancer.
Doll KM, Khor S, Odem-Davis K, et al.
American journal of obstetrics and gynecology 2018; (219(6)):593.e1-593.e14 doi:10.1016/j.ajog.2018.09.040.
PMID: 30291839 - 24
Molecular Genetics of Endometrial Carcinoma.
Bell DW, Ellenson LH
Annual review of pathology 2019; (14()):339-367 doi:10.1146/annurev-pathol-020117-043609.
PMID: 30332563 - 25
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
Wortman BG, Creutzberg CL, Putter H, et al.
British journal of cancer 2018; (119(9)):1067-1074 doi:10.1038/s41416-018-0310-8.
PMID: 30356126 - 26
Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results.
Delishaj D, Barcellini A, D'Amico R, et al.
Journal of contemporary brachytherapy 2018; (10(6)):559-566 doi:10.5114/jcb.2018.79713.
PMID: 30662479 - 27
Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies.
Jennings JJ, Mandaliya R, Nakshabandi A, Lewis JH
Expert opinion on drug metabolism & toxicology 2019; (15(3)):231-244 doi:10.1080/17425255.2019.1574744.
PMID: 30677306 - 28
Sentinel node navigation surgery in cervical and endometrial cancer: a review.
Niikura H, Tsuji K, Tokunaga H, et al.
Japanese journal of clinical oncology 2019; (49(6)):495-500 doi:10.1093/jjco/hyz062.
PMID: 31070770 - 29
Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.
Clarke MA, Devesa SS, Harvey SV, Wentzensen N
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019; (37(22)):1895-1908 doi:10.1200/JCO.19.00151.
PMID: 31116674 - 30
The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis.
Saed L, Varse F, Baradaran HR, et al.
BMC cancer 2019; (19(1)):527 doi:10.1186/s12885-019-5748-4.
PMID: 31151429 - 31
p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis.
Parra-Herran C, Bassiouny D, Lerner-Ellis J, et al.
The American journal of surgical pathology 2019; (43(12)):1591-1599 doi:10.1097/PAS.0000000000001328.
PMID: 31335355 - 32
Study of the Efficacy of Pipelle Biopsy Technique to Diagnose Endometrial Diseases in Abnormal Uterine Bleeding.
Ilavarasi CR, Jyothi GS, Alva NK
Journal of mid-life health 2019; (10(2)):75-80 doi:10.4103/jmh.JMH_109_18.
PMID: 31391756 - 33
Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors.
Fukihara J, Sakamoto K, Koyama J, et al.
Clinical lung cancer 2019; (20(6)):442-450.e4 doi:10.1016/j.cllc.2019.07.006.
PMID: 31446020 - 34
Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management.
Shivaji UN, Jeffery L, Gui X, et al.
Therapeutic advances in gastroenterology 2019; (12()):1756284819884196 doi:10.1177/1756284819884196.
PMID: 31723355 - 35
Sentinel lymph node biopsy for robotic-assisted endometrial cancer staging: further improvement of perioperative outcomes.
Casarin J, Multinu F, Tortorella L, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(1)):41-47 doi:10.1136/ijgc-2019-000672.
PMID: 31780567 - 36
Exploring the acceptability and feasibility of patient-initiated follow-up for women treated for stage I endometrial cancer.
Beaver K, Martin-Hirsch P, Williamson S, Kyrgiou M
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2020; (44()):101704 doi:10.1016/j.ejon.2019.101704.
PMID: 31812918 - 37
Adjuvant chemotherapy in endometrial cancer.
Gómez-Raposo C, Merino Salvador M, Aguayo Zamora C, Casado Saenz E
Cancer chemotherapy and pharmacology 2020; (85(3)):477-486 doi:10.1007/s00280-019-04027-6.
PMID: 31950214 - 38
Impact of quality of care on racial disparities in survival for endometrial cancer.
Huang AB, Huang Y, Hur C, et al.
American journal of obstetrics and gynecology 2020; (223(3)):396.e1-396.e13 doi:10.1016/j.ajog.2020.02.021.
PMID: 32109459 - 39
External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
Narasimhulu DM, Cope A, Riaz IB, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(6)):797-805 doi:10.1136/ijgc-2020-001199.
PMID: 32221021 - 40
FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis.
Arora S, Balasubramaniam S, Zhang W, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020; (26(19)):5062-5067 doi:10.1158/1078-0432.CCR-19-3979.
PMID: 32295834 - 41
Clinicopathologic Characteristics and Causes of Postmenopausal Bleeding in Older Patients.
Jo HC, Baek JC, Park JE, et al.
Annals of geriatric medicine and research 2018; (22(4)):189-193 doi:10.4235/agmr.18.0042.
PMID: 32743272 - 42
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
León-Castillo A, de Boer SM, Powell ME, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(29)):3388-3397 doi:10.1200/JCO.20.00549.
PMID: 32749941 - 43
Incidence of lymphedema in the lower limbs and lymphocyst formation within one year of surgery for endometrial cancer: A prospective longitudinal multicenter study.
Wedin M, Stålberg K, Marcickiewicz J, et al.
Gynecologic oncology 2020; (159(1)):201-208 doi:10.1016/j.ygyno.2020.07.014.
PMID: 32763108 - 44
The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ, McMahon R, Tobi S, et al.
PLoS medicine 2020; (17(9)):e1003263 doi:10.1371/journal.pmed.1003263.
PMID: 32941469 - 45
ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer.
, Reinhold C, Ueno Y, et al.
Journal of the American College of Radiology : JACR 2020; (17(11S)):S472-S486 doi:10.1016/j.jacr.2020.09.001.
PMID: 33153558 - 46
Fertility-sparing treatment in women with endometrial cancer.
Won S, Kim MK, Seong SJ
Clinical and experimental reproductive medicine 2020; (47(4)):237-244 doi:10.5653/cerm.2020.03629.
PMID: 33181010 - 47
Signs and symptoms associated with uterine cancer in pre- and postmenopausal women.
Boeckstaens S, Dewalheyns S, Heremans R, et al.
Heliyon 2020; (6(11)):e05372 doi:10.1016/j.heliyon.2020.e05372.
PMID: 33204876 - 48
Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer.
Glaser G, Dinoi G, Multinu F, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2021; (31(1)):85-91 doi:10.1136/ijgc-2020-001924.
PMID: 33243776 - 49
The struggle against endometrial cancer: ten years of experience of a tertiary center.
Bilgi A, Guler AH, Kulhan M, et al.
Ginekologia polska 2022; (93(5)):351-360 doi:10.5603/GP.a2021.0138.
PMID: 34155618 - 50
Obesity increases endometrial cancer risk in Chinese women with postmenopausal bleeding.
Liu F, Cheung ECW, Lao TT
Menopause (New York, N.Y.) 2021; (28(10)):1093-1098 doi:10.1097/GME.0000000000001822.
PMID: 34183566 - 51
Consecutive severe immune-related adverse events after PD-1 inhibitor induction and surgery in locally advanced non-small cell lung cancer: a case report.
Zhao H, Ning J, Gu Y, et al.
Translational lung cancer research 2021; (10(8)):3682-3688 doi:10.21037/tlcr-21-603.
PMID: 34584866 - 52
Association of Myometrial Invasion With Lymphovascular Space Invasion, Lymph Node Metastasis, Recurrence, and Overall Survival in Endometrial Cancer: A Meta-Analysis of 79 Studies With 68,870 Patients.
Wang J, Xu P, Yang X, et al.
Frontiers in oncology 2021; (11()):762329 doi:10.3389/fonc.2021.762329.
PMID: 34746002 - 53
Clinical issues of surgery for uterine endometrial cancer in Japan.
Nagai T, Shimada M, Tokunaga H, et al.
Japanese journal of clinical oncology 2022; (52(4)):346-352 doi:10.1093/jjco/hyab211.
PMID: 35032166 - 54
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, et al.
The New England journal of medicine 2022; (386(5)):437-448 doi:10.1056/NEJMoa2108330.
PMID: 35045221 - 55
Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients.
Zou J, Huang P, Ge N, et al.
Journal of gastrointestinal oncology 2022; (13(4)):1898-1906 doi:10.21037/jgo-22-643.
PMID: 36092355 - 56
Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.
Uccella S, Zorzato PC, Dababou S, et al.
Medicina (Kaunas, Lithuania) 2022; (58(9)) doi:10.3390/medicina58091256.
PMID: 36143933 - 57
Uterine disorders and iron deficiency anemia.
Donnez J, Carmona F, Maitrot-Mantelet L, et al.
Fertility and sterility 2022; (118(4)):615-624 doi:10.1016/j.fertnstert.2022.08.011.
PMID: 36182260 - 58
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline.
Harkenrider MM, Abu-Rustum N, Albuquerque K, et al.
Practical radiation oncology 2023; (13(1)):41-65 doi:10.1016/j.prro.2022.09.002.
PMID: 36280107 - 59
Endometrial Hyperplasia.
Ring KL, Mills AM, Modesitt SC
Obstetrics and gynecology 2022; (140(6)):1061-1075 doi:10.1097/AOG.0000000000004989.
PMID: 36357974 - 60
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
Kurokawa K, Mitsuishi Y, Shimada N, et al.
Thoracic cancer 2023; (14(5)):442-449 doi:10.1111/1759-7714.14761.
PMID: 36523162 - 61
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(1)):109-117 doi:10.1136/ijgc-2022-004039.
PMID: 36600534 - 62
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update.
Makker V, Aghajanian C, Cohn AL, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023; (41(5)):974-979 doi:10.1200/JCO.22.01021.
PMID: 36608305 - 63
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Meixner E, Wark A, Forster T, et al.
Radiation oncology (London, England) 2023; (18(1)):5 doi:10.1186/s13014-023-02198-4.
PMID: 36624483 - 64
"The Great Masquerader": An Interesting Case Series of Pulmonary Thromboembolism.
Sritharan SB, Raj CP, Ta V, et al.
Cureus 2022; (14(12)):e32330 doi:10.7759/cureus.32330.
PMID: 36632266 - 65
Biomarker-driven therapy in endometrial cancer.
Karpel H, Slomovitz B, Coleman RL, Pothuri B
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(3)):343-350 doi:10.1136/ijgc-2022-003676.
PMID: 36878569 - 66
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
Eskander RN, Sill MW, Beffa L, et al.
The New England journal of medicine 2023; (388(23)):2159-2170 doi:10.1056/NEJMoa2302312.
PMID: 36972022 - 67
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, et al.
The New England journal of medicine 2023; (388(23)):2145-2158 doi:10.1056/NEJMoa2216334.
PMID: 36972026 - 68
Endometrial biopsy: Indications, techniques and recommendations. An evidence-based guideline for clinical practice.
Vitale SG, Buzzaccarini G, Riemma G, et al.
Journal of gynecology obstetrics and human reproduction 2023; (52(6)):102588 doi:10.1016/j.jogoh.2023.102588.
PMID: 37061093 - 69
Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group.
Oliver-Perez MR, Padilla-Iserte P, Arencibia-Sanchez O, et al.
Cancers 2023; (15(9)) doi:10.3390/cancers15092612.
PMID: 37174081 - 70
An atypical presentation of endometrial cancer as angina secondary to critically low hemoglobin and iron deficiency associated pancytopenia: A case report.
Crawford G, Bahabri A, P'ng S
Case reports in women's health 2023; (38()):e00509 doi:10.1016/j.crwh.2023.e00509.
PMID: 37180555 - 71
Conservative treatment of endometrial cancer in women of reproductive age (Review).
Bourou MZ, Matsas A, Vrekoussis T, et al.
Molecular and clinical oncology 2023; (19(1)):55 doi:10.3892/mco.2023.2651.
PMID: 37323245 - 72
FIGO staging of endometrial cancer: 2023.
Berek JS, Matias-Guiu X, Creutzberg C, et al.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2023; (162(2)):383-394 doi:10.1002/ijgo.14923.
PMID: 37337978 - 73
The role of TCGA molecular classification in clear cell endometrial carcinoma.
Tang X, Hu Y
Frontiers in oncology 2023; (13()):1147394 doi:10.3389/fonc.2023.1147394.
PMID: 37456263 - 74
FIGO staging of endometrial cancer: 2023.
Berek JS, Matias-Guiu X, Creutzberg C, et al.
Journal of gynecologic oncology 2023; (34(5)):e85 doi:10.3802/jgo.2023.34.e85.
PMID: 37593813 - 75
Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy.
Yao M, Ma J, Wu D, et al.
Frontiers in immunology 2023; (14()):1198952 doi:10.3389/fimmu.2023.1198952.
PMID: 37680629 - 76
PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trial.
Loukovaara M, Bützow R, Staff S, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(11)):1807-1811 doi:10.1136/ijgc-2023-004939.
PMID: 37813479 - 77
Comparing endometrial biopsy results with hysteroscopic pathology in women presenting with abnormal and postmenopausal uterine bleeding.
Ferrando CA, Lintel MK, Bradley LD
Journal of gynecology obstetrics and human reproduction 2023; (52(10)):102685 doi:10.1016/j.jogoh.2023.102685.
PMID: 37871649 - 78
Sentinel lymph node mapping in endometrial cancer: Current evidence and practice.
Salman L, Cusimano MC, Marchocki Z, Ferguson SE
Journal of surgical oncology 2024; (129(1)):117-119 doi:10.1002/jso.27550.
PMID: 38059317 - 79
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on the Use of Primary Chemoimmunotherapy to Treat Patients with Locally Advanced or Recurrent Endometrial Cancer.
Tempfer C, Brucker S, Juhasz-Boess I, et al.
Geburtshilfe und Frauenheilkunde 2023; (83(9)):1095-1101 doi:10.1055/a-2145-1545.
PMID: 38230409 - 80
How deep is too deep? Assessing myometrial invasion as a predictor of distant recurrence in stage I endometrioid endometrial cancer.
Dinoi G, Garzon S, Weaver A, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2024; (34(9)):1389-1398.
PMID: 38821549 - 81
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.
Powell MA, Bjørge L, Willmott L, et al.
Annals of oncology : official journal of the European Society for Medical Oncology 2024; (35(8)):728-738 doi:10.1016/j.annonc.2024.05.546.
PMID: 38866180 - 82
A prospective study of endometrial histopathology in post-menopausal women in Jharkhand.
Kumari K, Paswan MK, Kundan M, Ambedkar SN
Journal of family medicine and primary care 2024; (13(5)):1696-1700 doi:10.4103/jfmpc.jfmpc_1331_23.
PMID: 38948580 - 83
New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles.
Yasuda M
Pathology international 2024; (74(10)):557-573 doi:10.1111/pin.13471.
PMID: 39175262 - 84
Impact of Vaginal Dilator Use and 68 Gy EQD2(α/β=3) Dose Constraint on Vaginal Complications in External Beam Irradiation Followed by Brachytherapy in Post-Operative Endometrial Cancer.
Noorian F, Abellana R, Zhang Y, et al.
Journal of personalized medicine 2024; (14(8)) doi:10.3390/jpm14080838.
PMID: 39202029 - 85
Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
Auranen A, Powell MA, Sukhin V, et al.
Therapeutic advances in medical oncology 2024; (16()):17588359241277656 doi:10.1177/17588359241277656.
PMID: 39346117 - 86
The advent of immune checkpoint inhibition for the treatment of patients with primary advanced or recurrent dMMR/MSI high endometrial cancer in 2025.
Silk T, Hacker KE, Growdon W, Pothuri B
Current opinion in obstetrics & gynecology 2025; (37(1)):22-29 doi:10.1097/GCO.0000000000001004.
PMID: 39611619 - 87
Quality of life and climacteric symptoms in women with endometrial cancer: examining the impact of lower limb lymphedema.
Li CC, Chang TC, Chang CW, et al.
Journal of patient-reported outcomes 2025; (9(1)):66 doi:10.1186/s41687-025-00895-0.
PMID: 40512268 - 88
Epidemiology, molecular typing, microbiome-immune interactions and treatment strategies of endometrial cancer: a review.
Liang B, Tan J, Li J, et al.
Frontiers in immunology 2025; (16()):1595638 doi:10.3389/fimmu.2025.1595638.
PMID: 40636107 - 89
Fertility-sparing treatments for patients with endometrial cancer: A comprehensive review.
Seol A, Jeong HG, Kim S, Lee S
Clinical and experimental reproductive medicine 2026; (53(1)):1-9 doi:10.5653/cerm.2023.06814.
PMID: 41069261 - 90
Performance of ultrasound and rates of guideline-concordant care in a diverse postmenopausal bleeding cohort.
Nolin AC, Atkins S, Brucker A, et al.
American journal of obstetrics and gynecology 2026; (234(2)):400-416 doi:10.1016/j.ajog.2025.10.002.
PMID: 41077302 - 91
Comparison of oncologic outcomes between completion hysterectomy and no completion hysterectomy in patients who achieved complete response and completed childbearing after fertility-sparing treatment for early-stage endometrial cancer: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3001).
Lee AJ, Jang EB, Suh DH, et al.
Gynecologic oncology 2025; (203()):191-197 doi:10.1016/j.ygyno.2025.10.036.
PMID: 41237702 - 92
Key considerations for safe de-escalation of therapy for POLE mutated endometrial cancer.
Martin SD, McAlpine JN
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2026; 102810 doi:10.1016/j.ijgc.2025.102810.
PMID: 41775567 - 93
Endometrial Cancer: A Review.
Mager KL, McLean K
JAMA 2026; (335(18)):1616-1627 doi:10.1001/jama.2026.2248.
PMID: 41973450 - 94
Visually Directed Hysteroscopic Biopsy in the Evaluation of Abnormal Uterine Bleeding and Postmenopausal Bleeding: A Joint Society Practice Guideline.
Journal of minimally invasive gynecology 2026; (33(8)):1027-1040 doi:10.1016/j.jmig.2026.06.018.
PMID: 42336133 - 95
Validation of the 2023 International Federation of Gynecology and Obstetrics staging system in a large retrospective cohort.
Demirden A, Keles E, Şanlıkan F, et al.
Revista da Associacao Medica Brasileira (1992) 2026; (72(3)):e20251624 doi:10.1590/1806-9282.20251624.
PMID: 42384971 - 96
Clinical utility of diagnosing Lynch syndrome in gynecologic oncology: a joint statement from four Japanese academic societies.
Sato S, Masuda K, Oda K, et al.
International journal of clinical oncology 2026; (31(9)):1742-1755 doi:10.1007/s10147-026-03126-8.
PMID: 42435282 - 97
Personalizing endometrial cancer care beyond histology: clinical applications and limits of molecular classification.
Marchetti M, Panizzolo E, Caruso G, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2026; (36(9)):104882 doi:10.1016/j.ijgc.2026.104882.
PMID: 42617416 - 98
A perspective on the revised American College of Obstetricians and Gynecologists' guidance for transvaginal ultrasound in the evaluation of postmenopausal bleeding.
Goldstein SR
Menopause (New York, N.Y.) 2026; doi:10.1097/GME.0000000000002902.
PMID: 42677969